ClinConnect ClinConnect Logo
Search / Trial NCT06177860

Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use

Launched by HOSPITAL EL CRUCE · Dec 10, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Myocardial Infarction Acute Coronary Syndrome Cocaine Use Cocaine Abuse

ClinConnect Summary

This clinical trial is studying the health effects of cocaine use on patients who have experienced Acute Coronary Syndrome (ACS), which is a term that describes a range of conditions related to sudden reduced blood flow to the heart, often leading to a heart attack. The researchers want to learn more about how cocaine use influences the severity of heart disease and to compare these patients with those who have ACS but do not use cocaine. This is important because there is limited information on this topic in Argentina, where cocaine use has been rising.

To participate in the study, you need to be at least 18 years old and have been hospitalized for ACS as confirmed by your doctor. If you decide to join, you'll be asked to share information about your health and cocaine use. The study will involve collecting data from patients in a hospital and will not interfere with your regular treatment. Your participation will help researchers better understand the connection between cocaine use and heart disease, which could improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥18
  • Hospitalization due to diagnosis of ACS, made by the treating medical team.
  • For the prospective stage, it will be added:
  • Acceptance to participate in the study and willingness to sign the informed consent.
  • Exclusion Criteria:
  • Patients who, due to their clinical condition, cannot be interviewed to determine their history of cocaine use.

About Hospital El Cruce

Hospital El Cruce is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Buenos Aires, Argentina, the hospital is renowned for its multidisciplinary approach, combining cutting-edge technology with a commitment to evidence-based practices. As a clinical trial sponsor, Hospital El Cruce prioritizes patient safety and ethical standards while fostering collaboration with researchers and healthcare professionals. The institution aims to contribute valuable insights to the medical community by exploring new therapies and treatment modalities across various fields, ultimately enhancing the quality of care for diverse patient populations.

Locations

Florencio Varela, Buenos Aires, Argentina

Patients applied

0 patients applied

Trial Officials

Maximiliano de Abreu, PhD

Principal Investigator

Hospital El Cruce

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported